How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?

Thanyada Rungrotmongkol1, Thanyarat Udommaneethanakit, Maturos Malaisree

  • 1Computational Chemistry Unit Cell, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.

Biophysical Chemistry
|September 8, 2009
PubMed

Insights

Oseltamivir resistance in H5N1 influenza arises from specific mutations. Molecular simulations reveal how H274Y and N294S mutations alter drug-target interactions, impacting neuraminidase inhibitor efficacy.

Area of Science:

  • Virology
  • Computational Biology
  • Drug Discovery

Background:

  • Influenza A (H5N1) poses a significant pandemic threat.
  • Neuraminidase inhibitors like oseltamivir are crucial for treatment.
  • Emergence of drug-resistant strains necessitates understanding resistance mechanisms.

Purpose of the Study:

  • To elucidate the molecular basis of oseltamivir resistance in H5N1 influenza.
  • To investigate the impact of specific mutations (H274Y, N294S) on drug-target interactions.
  • To identify key residues and conformational changes conferring resistance.

Main Methods:

  • Molecular Dynamics (MD) and Linear Interaction Energy (LIE) simulations were employed.
  • Analysis of drug-target interactions at functional group levels.
  • Investigation of electrostatic, van der Waals energies, hydrogen bonds, and residue conformations.

Main Results:

  • The H274Y mutation significantly weakens electrostatic and van der Waals interactions of oseltamivir, primarily due to altered hydrogen bonds and distances to N1 residues.
  • The N294S mutation shows minimal changes in binding energies and intermolecular interactions.
  • Conformational changes in E276 play a critical role, influencing hydrophobicity and pocket size in H274Y, and acting as a hydrogen bond center in N294S.

Conclusions:

  • H274Y mutation confers high-level oseltamivir resistance by disrupting key drug-binding interactions.
  • N294S mutation confers medium-level resistance through subtle alterations in binding and E276 conformation.
  • Molecular insights into these resistance mechanisms are vital for developing effective antiviral strategies against H5N1 influenza.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
ortho–para-Directing Deactivators: Halogens01:24

ortho–para-Directing Deactivators: Halogens

Halogens are ortho–para directors. They are more electronegative than carbon. Therefore, as ring substituents, they can withdraw electrons through the inductive effect and deactivate the aromatic ring towards electrophilic substitution. Halogens also have an electron-donating resonance effect on the ring, which influences the orientation of the incoming electrophile. If an electrophile attacks at the ortho or the para position, the halogen donates electrons and stabilizes the intermediate...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Leaving Groups02:14

Leaving Groups

The nature of leaving groups strongly influences the outcome of a nucleophilic substitution reaction.
In general, in a nucleophilic substitution reaction, a nucleophile displaces a functional group, called the leaving group, from the substrate to give a substituted product. A leaving group departs the substrate molecule through heterolytic cleavage, taking the pair of electrons with it to become a relatively stable weak base in the form of an anion or a neutral molecule.  
In a nucleophilic...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...